Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pressor Responses to Antihypertensive Drug Types
M. H. Alderman, Hillel W. Cohen, J. E. Sealey, et al.
American Journal of Hypertension (2010) Vol. 23, Iss. 9, pp. 1031-1037
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Hypertension
Luuk te Riet, Joep H.M. van Esch, Anton J.M. Roks, et al.
Circulation Research (2015) Vol. 116, Iss. 6, pp. 960-975
Open Access | Times Cited: 611
The Plasma Renin Test Reveals the Contribution of Body Sodium-Volume Content (V) and Renin-Angiotensin (R) Vasoconstriction to Long-Term Blood Pressure
J. H. Laragh, J E Sealey
American Journal of Hypertension (2011) Vol. 24, Iss. 11, pp. 1164-1180
Open Access | Times Cited: 136
Combination Therapy Is Superior to Sequential Monotherapy for the Initial Treatment of Hypertension: A Double‐Blind Randomized Controlled Trial
Thomas M. MacDonald, Bryan Williams, David J. Webb, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 11
Open Access | Times Cited: 115
Efficacy and safety of mineralocorticoid receptor antagonists for the treatment of low-renin hypertension: a systematic review and meta-analysis
Sonali Shah, Jinghong Zhang, Stella May Gwini, et al.
Journal of Human Hypertension (2024) Vol. 38, Iss. 5, pp. 383-392
Open Access | Times Cited: 13
Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy
Lama Ghazi, Paul E. Drawz
F1000Research (2017) Vol. 6, pp. 297-297
Open Access | Times Cited: 67
Genomic Association Analysis Identifies Multiple Loci Influencing Antihypertensive Response to an Angiotensin II Receptor Blocker
Stephen T. Turner, Kent R. Bailey, Gary L. Schwartz, et al.
Hypertension (2012) Vol. 59, Iss. 6, pp. 1204-1211
Open Access | Times Cited: 65
Rapid and non-invasive screening of high renin hypertension using Raman spectroscopy and different classification algorithms
Xiangxiang Zheng, Guodong Lv, Ying Zhang, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2019) Vol. 215, pp. 244-248
Closed Access | Times Cited: 41
Enduring Direct Association of Baseline Plasma Renin Activity With All-Cause and Cardiovascular Mortality in Hypertensive Patients
M. C. Gonzalez, Hillel W. Cohen, J. E. Sealey, et al.
American Journal of Hypertension (2011) Vol. 24, Iss. 11, pp. 1181-1186
Open Access | Times Cited: 43
Rational use of antihypertensive medications in children
Michael A. Ferguson, Joseph T. Flynn
Pediatric Nephrology (2013) Vol. 29, Iss. 6, pp. 979-988
Closed Access | Times Cited: 38
Renin and Aldosterone Measurements in the Management of Arterial Hypertension
A. Viola, Silvia Monticone, Jacopo Burrello, et al.
Hormone and Metabolic Research (2015) Vol. 47, Iss. 06, pp. 418-426
Open Access | Times Cited: 30
Head motion in the UK Biobank imaging subsample: longitudinal stability, associations with psychological and physical health, and risk of incomplete data
Joey Ward, Simon R. Cox, Terence J. Quinn, et al.
Brain Communications (2024) Vol. 6, Iss. 4
Open Access | Times Cited: 3
Plasma Renin Activity (PRA) Levels and Antihypertensive Drug Use in a Large Healthcare System
John J. Sim, S. K. Bhandari, Jiaxiao Shi, et al.
American Journal of Hypertension (2011) Vol. 25, Iss. 3, pp. 379-388
Open Access | Times Cited: 28
Personalised medicine for hypertension
Mark J. Brown
BMJ (2011) Vol. 343, Iss. jul28 2, pp. d4697-d4697
Closed Access | Times Cited: 27
Renin-Guided Treatment of Hypertension: Time for Action
Curt D. Furberg
American Journal of Hypertension (2010) Vol. 23, Iss. 9, pp. 929-930
Open Access | Times Cited: 27
Personalized vascular medicine: Individualizing drug therapy
Emil M. deGoma, Giovanni Rivera, Scott Lilly, et al.
Vascular Medicine (2011) Vol. 16, Iss. 5, pp. 391-404
Open Access | Times Cited: 24
Assessing the Associations of Sodium Intake With Long-Term All-Cause and Cardiovascular Mortality in a Hypertensive Cohort
Pamela Singer, Hillel W. Cohen, M. H. Alderman
American Journal of Hypertension (2014) Vol. 28, Iss. 3, pp. 335-342
Open Access | Times Cited: 21
Plasma Renin Activity–Guided Strategy for the Management of Hypertension
Nicole Olson, Beth DeJongh, Augustus Hough, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2012) Vol. 32, Iss. 5, pp. 446-455
Closed Access | Times Cited: 21
Heterogeneity of Blood Pressure Response to Therapy
Morris J. Brown
American Journal of Hypertension (2010) Vol. 23, Iss. 9, pp. 926-928
Open Access | Times Cited: 20
Cost-Effectiveness of Renin-Guided Treatment of Hypertension
Steven M. Smith, Jonathan D. Campbell
American Journal of Hypertension (2013) Vol. 26, Iss. 11, pp. 1303-1310
Open Access | Times Cited: 17
Epidemiology, Prognosis, and Treatment of Resistant Hypertension
Steven M. Smith
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2013) Vol. 33, Iss. 10, pp. 1071-1086
Closed Access | Times Cited: 14
Heterogeneity in Early Responses in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial)
Sanket S. Dhruva, Chenxi Huang, Erica S. Spatz, et al.
Hypertension (2017) Vol. 70, Iss. 1, pp. 94-102
Open Access | Times Cited: 14
Plasma renin activity and risk of cardiovascular and mortality outcomes among individuals with elevated and nonelevated blood pressure
Simran K. Bhandari, Michael Batech, Jiaxiao Shi, et al.
Kidney Research and Clinical Practice (2016) Vol. 35, Iss. 4, pp. 219-228
Open Access | Times Cited: 12
Renin and prorenin as biomarkers in hypertension
A.H. Jan Danser
Current Opinion in Nephrology & Hypertension (2012) Vol. 21, Iss. 5, pp. 508-514
Closed Access | Times Cited: 13
Renin Test-Guided Drug Treatment of Hypertension: The Need For Clinical Trials
C. D. Furberg
American Journal of Hypertension (2011) Vol. 24, Iss. 11, pp. 1158-1163
Open Access | Times Cited: 13
Clinical and molecular approaches to individualize antihypertensive drug therapy
Timo P. Hiltunen, Kimmo Kontula
Annals of Medicine (2012) Vol. 44, Iss. sup1, pp. S23-S29
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top